Trending Content
Career Resources
WSO Free Modeling Series - Now Open Through
April 30, 2024
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
bump
ER and PE are extremely difficult. IB is possible if you network extensively are lucky in getting an interview. Exit opportunities are much more realistic and achievable when you are at the staff level.
.
From what I've seen, ER and IB are both in the cards. Don't sit around waiting for them to find you though.
IB, ER, Esuric exited to Corp Dev from Big 4 valuation. I work in valuation for a non-big 4 (BDO/ Grant Thorton/ Weaver) and in my short time here ppl at my firm have left for IB and management consulting. To be fair that's non-MBB and lower level mid market firms.
This is a complicated question. I had an AMA that went into greater detail but unfortunately it was hijaked by trolls. That said, the exits vary somewhat dramatically by group. Big 4, with the possible exception of EY (haven't interacted with them) is broken down by industry vertical: TMT, Life Sciences, Financial Sponsors, Complex Securities (CLOs, RMBS, etc.), Aerospace and Industrial 's, real estate, etc.
Those that work for financial sponsors have a greater probability of exiting into PE and those that work in Life Sciences have a better shot at CorpDev/boutique strategy consulting. Life Sciences will give you a shot at VC while Compex Securities won't. I could go on but I think you get it.
If I had to generalize, I would categorize the likely exists as follows, in order to descending likelihood:
I should note that this does not consider bval to bval transfers, which is obviously the most likely exit. The list only considers exits from bval into something else. The list also considers the bval industry as a whole. For example, the list cites that about 5% go into PE but this is a very common exit for those in real estate valuation groups. The thing is that those groups tend to be very lean and thus only make up a small portion of the industry.
There are some nuances here. For example, I mentioned that MBB placements are basically unheard of. That said, if you work for Deloitte bval in NYC, you'll frequently be staffed on Monitor engagement (if you're good). You'll work for Monitor partners, in the Monitor building, etc. This is obviously advantageous for those looking to exit into strategy. So while MBB is basically unheard of, exits to LEK/Parthenon aren't.
What are some possible exit opps for folks in complex securities?
.
Tagging this as I am also interested in insight into complex securities possibilities.
Would you be able to comment on the valuation exits from the mega funds? Currently analyst on valuations team for a specific sector at a mega fund; PE valuations focused on (core PE, growth equity, lifescience, etc.) any insight here would greatly be appreciated.
Thanks!
Nostrum repudiandae explicabo qui doloribus. Voluptatibus dolore et soluta saepe aperiam debitis. Qui inventore assumenda magni sequi commodi assumenda consectetur. Quis et et quod aut in ut magni.
Quidem temporibus distinctio sed quia. Dolores sed quod qui omnis quam at dolorem.
At molestias aut harum ipsam optio omnis impedit. Ullam veritatis quos illo. Laudantium vel aut dicta ut ex aut et consequatur. Eos quia quia quia dolorem. Sed ad dolores est laboriosam consequatur error.
Et hic numquam doloribus sed. Et neque quaerat dignissimos debitis. Quia ut aliquid reprehenderit laborum. Atque odio rem similique ipsum perferendis. Reiciendis recusandae aut unde quaerat velit illo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...